Provided by Tiger Fintech (Singapore) Pte. Ltd.

Meiragtx Holdings Plc

8.37
+0.06000.72%
Post-market: 8.370.00000.00%16:11 EDT
Volume:389.94K
Turnover:3.25M
Market Cap:672.66M
PE:-3.68
High:8.49
Open:8.32
Low:8.18
Close:8.31
Loading ...

CFO & COO Richard Giroux Reports Disposal of Common Shares in MeiraGTx Holdings plc

Reuters
·
23 Jul

President & CEO Alexandria Forbes Reports Disposal of Common Shares of MeiraGTx Holdings plc

Reuters
·
09 Jul

MeiraGTx Holdings - Receives UK Regulatory Approvals for Proposed Transactions With Hologen, Expected to Close in July 2025 - SEC Filing

THOMSON REUTERS
·
26 Jun

MeiraGTx Holdings plc Receives UK Regulatory Approvals for Proposed Transactions with Hologen Limited, Expected to Close in July 2025

Reuters
·
26 Jun

MeiraGTx Holdings plc Conducted Annual Shareholders Meeting

Reuters
·
17 Jun

Meiragtx Holdings (MGTX) Receives a New Rating from Lucid Capital

TIPRANKS
·
10 Jun

Chardan Adjusts MeiraGTx Price Target to $35 From $38, Maintains Buy Rating

MT Newswires Live
·
14 May

MeiraGTx Holdings Is Maintained at Buy by Chardan Capital

Dow Jones
·
14 May

ADVISORY-Dated alert on MeiraGTx collaboration with Hologen AI withdrawn

Reuters
·
13 May

MeiraGTx Hldgs Q1 EPS $(0.51) Misses $(0.45) Estimate, Sales $1.93M Miss $4.43M Estimate

Benzinga
·
13 May

MeiraGTx Holdings PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

MeiraGTx Holdings Plc - Announces $200 Million Strategic Collaboration With Hologen AI - SEC Filing

THOMSON REUTERS
·
13 May

MeiraGTx Holdings plc Reports Q1 2025 Results: Decrease in Interest Expense and Gain on Foreign Currency, No Gain on Sale of Nonfinancial Assets

Reuters
·
13 May

BRIEF-MeiraGTx Q1 EPS USD -0.51

Reuters
·
13 May

MeiraGTx Q1 EPS USD -0.51

THOMSON REUTERS
·
13 May

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live
·
10 May

MeiraGTx Shares up 4% After Co Receives FDA's Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Treatment

THOMSON REUTERS
·
09 May

MeiraGTx Shares Jump 11.5% Premarket After Co Receives FDA's Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Treatment

THOMSON REUTERS
·
09 May

MeiraGTx Says FDA Granted RMAT Designation to AAV-GAD for Treating Parkinson's; Shares Up Pre-Bell

MT Newswires Live
·
09 May

MeiraGTx- Granted FDA Regenerative Medicine Advanced Therapy Designation for Aav-Gad for Treatment of Parkinson’s Disease

THOMSON REUTERS
·
09 May